Related Experiment Video
Updated: Jul 3, 2025

Separating Bacteria by Capsule Amount Using a Discontinuous Density Gradient
Published on: January 7, 2019
Klebsiella pneumoniae K2 capsular polysaccharide degradation by a bacteriophage depolymerase does not require trimer
Ting-Juan Ye1, Kit-Man Fung1, I-Ming Lee2
1Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.
Abstract:
K2-capsular Klebsiella pneumoniae is a hypervirulent pathogen that causes fatal infections. Here, we describe a phage tailspike protein, named K2-2, that specifically depolymerizes the K2 capsular polysaccharide (CPS) of K. pneumoniae into tetrasaccharide repeating units. Nearly half of the products contained O-acetylation, which was thought crucial to the immunogenicity of CPS. The product-bound structures of this trimeric enzyme revealed intersubunit carbohydrate-binding grooves, each accommodating three tetrasaccharide units of K2 CPS. The catalytic residues and the key interactions responsible for K2 CPS recognition were identified and verified by site-directed mutagenesis. Further biophysical and functional characterization, along with the structure of a tetrameric form of K2-2, demonstrated that the formation of intersubunit catalytic center does not require trimerization, which could be nearly completely disrupted by a single-residue mutation in the C-terminal domain. Our findings regarding the assembly and catalysis of K2-2 provide cues for the development of glycoconjugate vaccines against K. pneumoniae infection.
Importance:
Generating fragments of capsular polysaccharides from pathogenic bacteria with crucial antigenic determinants for vaccine development continues to pose challenges. The significance of the C-terminal region of phage tailspike protein (TSP) in relation to its folding and trimer formation remains largely unexplored. The polysaccharide depolymerase described here demonstrates the ability to depolymerize the K2 CPS of K. pneumoniae into tetrasaccharide fragments while retaining the vital O-acetylation modification crucial for immunogenicity. By carefully characterizing the enzyme, elucidating its three-dimensional structures, conducting site-directed mutagenesis, and assessing the antimicrobial efficacy of the mutant enzymes against K2 K. pneumoniae, we offer valuable insights into the mechanism by which this enzyme recognizes and depolymerizes the K2 CPS. Our findings, particularly the discovery that trimer formation is not required for depolymerizing activity, challenge the current understanding of trimer-dependent TSP activity and highlight the catalytic mechanism of the TSP with an intersubunit catalytic center.
Insights
A novel phage tailspike protein, K2-2, depolymerizes K2 capsular polysaccharide from Klebsiella pneumoniae, retaining O-acetylation crucial for vaccine development. Trimer formation is not required for its catalytic activity.
Area of Science:
- Microbiology
- Structural Biology
- Biochemistry
Background:
- Hypervirulent Klebsiella pneumoniae infections pose a significant threat.
- Generating immunogenic capsular polysaccharide fragments for vaccines is challenging.
- The role of the C-terminal region in phage tailspike protein (TSP) folding and trimerization is poorly understood.
Purpose of the Study:
- To characterize a phage tailspike protein (K2-2) that depolymerizes K2 capsular polysaccharide (CPS) from K. pneumoniae.
- To elucidate the structure and catalytic mechanism of K2-2.
- To investigate the role of trimerization in TSP activity and its implications for vaccine development.
Main Methods:
- Structural elucidation of the K2-2 enzyme in trimeric and tetrameric forms.
- Site-directed mutagenesis to identify catalytic residues and assess functional impact.
- Biophysical and functional characterization of enzyme activity.
- Analysis of O-acetylation on depolymerized CPS fragments.
Main Results:
- K2-2 specifically depolymerizes K2 CPS into tetrasaccharide units, preserving O-acetylation.
- Structural analysis revealed intersubunit carbohydrate-binding grooves accommodating CPS fragments.
- Catalytic activity was confirmed to be independent of trimer formation, with a single mutation disrupting trimerization.
- Mutant enzyme efficacy against K2 K. pneumoniae was assessed.
Conclusions:
- The K2-2 enzyme provides a novel tool for generating vaccine-relevant CPS fragments.
- The findings challenge the paradigm of trimer-dependent TSP activity.
- Understanding K2-2's catalytic mechanism offers insights for designing anti-K. pneumoniae glycoconjugate vaccines.
Related Concept Videos
Lysogenic Cycle of Bacteriophages
Lytic Cycle of Bacteriophages
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

